Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/24028

Title: Sustained clinically meaningful improvements in walking ability with prolonged-release fampridine: results from the placebo-controlled ENHANCE study.
Authors: Hobart, Jeremy
Ziemssen, T.
Feys, Peter
Linnebank, M.
Goodman, A.
Farrell, R.
Englishby, V.
McNeill, M.
Chang, I.
Mehta, L.
Elkins, J.
Issue Date: 2016
Citation: MULTIPLE SCLEROSIS JOURNAL, 22, p. 833-834 (Art N° 254)
Notes: [Hobart, J.] Plymouth Univ, Peninsula Sch Med, Plymouth Hosp NHS Trust, Plymouth, Devon, England. [Hobart, J.] Plymouth Univ, Peninsula Sch Dent, Plymouth Hosp NHS Trust, Plymouth, Devon, England. [Ziemssen, T.] Univ Clin Dresden, Dresden, Germany. [Feys, P.] Univ Hasselt, Diepenbeek, Belgium. [Linnebank, M.] Univ Zurich Hosp, Zurich, Switzerland. [Goodman, A.] Univ Rochester, Sch Med & Dent, Rochester, NY USA. [Farrell, R.] Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, London, England. [Englishby, V.; McNeill, M.] Biogen, Maidenhead, Berks, England. [Chang, I.; Mehta, L.; Elkins, J.] Biogen, Cambridge, MA USA.
URI: http://hdl.handle.net/1942/24028
Link to publication: https://onlinelibrary.ectrims-congress.eu/ectrims/2016/32nd/147081/jeremy.hobart.sustained.clinically.meaningful.improvements.in.walking.ability.html?f=m3
ISI #: 000383267203260
ISSN: 1352-4585
Category: M
Type: Journal Contribution
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
N/A252.66 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.